Search

Your search keyword '"Pilkington, Clarissa A."' showing total 527 results

Search Constraints

Start Over You searched for: Author "Pilkington, Clarissa A." Remove constraint Author: "Pilkington, Clarissa A."
527 results on '"Pilkington, Clarissa A."'

Search Results

1. Juvenile Dermatomyositis

2. Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings

3. Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study

4. OA36 Systemic juvenile idiopathic arthritis: the Great Ormond Street Hospital experience (2005-2021)

5. Mental health in paediatric and adult myositis-related diseases: current state of research, interventions, and future steps from the MIHRA Psychological Impact Scientific Working Group

6. Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts

7. Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022

9. Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022.

13. Rheumatology

14. OA39 Development of a Childhood Lupus Low Disease Activity State definition: recommendations from the International Childhood Lupus Treat-to-Target Task Force

15. Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus:PReS-endorsed overarching principles and points-to-consider from an international task force

16. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

17. Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis.

18. Proposed Response Parameters for Twelve‐MonthDrug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings

19. Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force

26. Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research

27. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups

28. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative

29. Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to- consider from an international task force.

31. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative

32. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria—methodological aspects

33. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative

34. Consensus-based recommendations for the management of juvenile dermatomyositis

35. The vascular phenotype of children with systemic lupus erythematosus

36. American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus

37. Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE

40. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease

41. Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus

42. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study

43. Whole-genome sequencing of patients with rare diseases in a national health system

44. Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study

45. Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis

46. Experience with the use of mycophenolate mofetil in juvenile idiopathic inflammatory myopathies.

47. Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE.

49. Contributors

Catalog

Books, media, physical & digital resources